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PLATE 1 
(Received for publication, July 23, 1952) 
The role of leukocytes in viral infections has never been fully defined. Early workers 
in  the  field  demonstrated  that  viruses were  not phagocytosed and  destroyed in  a 
fashion analogous to that of bacteria  (1-7).  In a  number of studies  virus has been 
found  to  be  associated  with  white  cells.  Smith  (6)  demonstrated  the  presence  of 
vaccinia virus in the leukocytes of rabbits after virus could no longer be isolated from 
whole blood.  Sabin  (5)  confirmed the  "fixation" of vaccinia virus by leukocytes in 
vitro, and interpreted his data to indicate that white cells were not viricidal for vac- 
cinia.  Other workers have failed  to demonstrate  inactivation  of certain viruses by 
leukocytes in vitro (5, 8, 13),  and in recent reviews of the work from his laboratory, 
Smorodintsev  (9,  10)  concluded that it demonstrated  "the inactivity of phagocytic 
defense  factors  in  all  virus  infections." 
Some workers have postulated  that viruses may be  disseminated  via leukocytes 
following observations that: (a)  some viruses replicate in white cells  (8,  11, 12),  and 
(b) virus may be recovered in an infectious form from leukocytes of infected animals 
(1, 3, 6, 13, 14). 
In contrast, more recent studies by several groups (13-16) have demonstrated ad- 
sorption and penetration or phagocytosis, but no multiplication of influenza virus in 
leukocytes. Ginsberg and Blackmon (13)  investigated the rate of adsorption of PR-8 
and Lee strains of influenza virus to guinea pig leukocytes. They were able to show 
that little or no virus eluted spontaneously and that less than 1 per cent of virus which 
did not elute could be demonstrated on disruption of the cells. Inglot and Davenport 
(14)  confirmed these findings and,  in addition,  demonstrated  that during a  20-hour 
period  of observation:  (a)  leukocyte-associated virus,  recoverable by disruption  of 
cells,  gradually decreased, and  (b)  influenza virus did not multiply in leukocytes. 
Nishmi and Bernkopf (17) observed a similar phenomenon in mouse leukocytes in- 
fected in vitro with vaccinia virus. Virus  fiters in the supernatant fluids decreased, 
and  they  obtained  no  evidence  of virus  multiplication  during  the  96-hour period 
studied. 
On the other hand, Florman and Enders (8) have reported multiplication of vac- 
cinia virus to low titers in rabbit mononuclear cells cultured in vitro. More recently 
Bang and Warwick (18)  and Goodman and Koprowski (19)  have investigated virus 
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replication in macrophage cultures. Mouse hepatitis (18)  was observed to multiply 
in macrophages grown from liver explants of genetically susceptible mice, but not in 
cultures from a  resistant strain. Similarly, resistance of peritoneal macrophage cul- 
tures  to group B  arbor viruses reflected the natural resistance of the mouse strain 
from which  they were derived  (19). 
The  role of interferon in  recovery from  viral infections has  recently been 
reviewed by Baron and Isaacs (20).  Production of interferon has been associ- 
ated  with recovery from in dvo infections with  O'nyong-nyong (21)  and  in- 
fluenza viruses in mice (22).  We have described two in vitro  models in which 
interferon appeared to contribute to the elimination of a  viral infection from 
tissue culture  (23,  24).  Gresser  (25)  first reported evidence which  associated 
interferon production with white blood cells, and suggested that in this manner 
leukocytes could contribute to the host's defense mechanism. 
The  present study was  initiated to investigate: (a)  the  course  of vaccinia 
virus infection of leukocytes; (b) the production of interferon by virus infected 
leukocytes, and  (c)  the contribution of leukocyte-produced interferon to  the 
host's defense mechanism. 
Materials and Methods 
Virus.--A calf lymph strain of vaccinia virus maintained by passage in monkey kidney 
cultures was obtained from Dr. Jod Warren. The virus pool was prepared in HeLa cells and 
titered 5 ×  10 ~ plaque-forming  units (pfu) per ml. 
Eneephalomyocarditis virus (EMC) used in interferon assays was a large plaque-forming 
mutant, EMC r, obtained from  Dr. K. K. Takemoto, National Institutes of Health. Virus 
pools were prepared in L cells and titered approximately 2 X  107 pfu per ml. 
Vesicular Stomatitis virus,  Indiana strain, (VSV) was obtained from the American Type 
Culture Collection.  Virus pools were grown in ME-29,  an established mouse embryo tissue 
culture line and titered 6 X  10 e pfu per mi in primary mouse embryo cell cultures. 
Chikungunya virus,  standard reference  strain, was obtained from  Dr.  Phlllip Russell, 
Waiter Reed Army Medical Center, Arbor Virus Unit, as 168th mouse brain passage. Virus 
pools were prepared by intraeerebrai (i.c.) inoculation of suckling, random-bred Swiss mice 
and titered approximately 2 X  107 pfu/mi. 
Ce//s.--Primary mouse embryo cells used in interferon assays were obtained by trypsiniza- 
tion of 13- to 15-day embryos from random-bred Swiss mice. Leukocytes were obtained from 
35 to 45 gm random-bred Swiss or inbred BALB/c mice.  Donor animals were  inoculated 
intraperitoneally (i.p.) with 1 to 2 ml of trypticase soy broth. White cell preparations con- 
taining I to 3 X  108 cells per ml were obtained 18 to 24 hours later by flushing the peritoneal 
cavity with 8 to 10 ml of Eagle's medium containing 1 per cent fetal calf serum. Differential 
counts of the peritoneal exudate carried out on Wright's stained preparations showed 42 to 
68 per cent polymorphonuclear and 32 to 58 per cent mononuelear calls. Leukocyte cultures 
were maintained in 60 mm plastic petri dishes (FalcOn Plastics, Los Angeles) in Eagle's  medium 
with 15 per cent calf serum at 36  ° in a 4 per cent CO  2 atmosphere. 
Virus Titrations.--Vaccmia virus was assayed by plaque method in HeLa ceils. Virus was 
adsorbed for 3 hours and overlaid with 5 ml. of agar medium.  A second overlay containing 
1:20,000 neutral red was made on the 4th or 5th day and plaques counted on the 5th through 
the 8th day. Agar medium used for plaque assay contained 0.9 per cent Noble agar in Earle's 
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Interferon Assay.--Culture fluids to be assayed for interferon were acidified with 6 N HCI 
to pH 2 and held for 22 to 24 hours. The pH was then adjusted to 7.2-7.4 with 5 ~ NaOH. 
Interferon preparations were free of infectious virus on inoculation of HeLa cultures. Inter- 
feron activity was assayed by the plaque reduction method. Monolayers of primary mouse 
embryo cells in plastic petri dishes were pretreated for 2 to 6 hours with 0.5 ml of the inter- 
feron or control preparations.  Fluids were then removed and plates inoculated with approxi- 
mately 50 pfu of EMC r virus. Mter 1 hour's adsorption, plates were overlayed with 5.0 ml 
of agar medium and incubated at 36°C. in the CO~ incubator. Plates were stained with neutral 
red, final concentration of 1: 30,000 at 24 hours and plaques counted at 28 and 48 hours. 
Interferon.--Control interferon was prepared by infecting an established mouse cell line, 
3-B  (23),  with 4  ×  106 pfu/ml of Chikungunya virus and harvesting the superuatant  at 2 
days. Preparations were freed of virus as described above. 
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TI~xT-FIG. 1.  Course of vaccinia virus infection with varying input multiplicities (M:  1, 
0.5,  0.1, 0.01)  in cultures of mouse leukocytes. Virus assays are plotted as pfu/ml. The con- 
trol  curve represents  the  thermal  inactivation of vaccinia virus in  medium  alone and  in 
medium containing heat-killed leukocytes. 
Inactivated virus.--Vaccinia virus (5  X  10 T  pfu/ml) was inactivated in a Habel-Sockrider 
ultraviolet apparatus as previously described (23). 
ttanagglutinin  Assay.--The  technique  described  in  "Diagnostic  Procedures  for  Virus 
and Rickettsial Diseases" was followed (26). 
Vaccinia ttyperimmune Serum.--Vaccinia antiserum was made in rabbits. A 1:20 dilution 
of serum incubated for 1/fi hour at 36  ° with 5  X  107 pfu of vaccinia virus neutralized 99.8 
per cent of the infectivity. 
P,.ESULTS 
In  Vitro  Interferon  Production  by  Leukocytes 
Lack  of  Viral  Multiplication  in  Mouse  Leukocytes.--Inifial  studies  were 
carried out to determine the course of vaccinia virus infection in mouse leuko- 
cytes  in vitro. 
Replicate cultures of white cells,  harvested from the peritoneal cavity as described, were 
inoculated with varying multiplicities of vaccinia virus. Samples of supernate were harvested 
periodically and assayed for virus. 
At  48  to  72  hours  after  infection  a  cytotoxic  effect was  noted  in  cultures 
inoculated with a  multiplicity of 0.5-1.0,  but not in those receiving less than 152  INTERFERON  PRODUCTION  BY  MOUSE  LEUKOCYTES 
0.5  pfu/cell.  (Figs.  1  and  2.)  This  cytotoxic effect appeared  similar  to  that 
described  by Nishmi and Bernkopf (17)  and was characterized by increased 
granularity  and  vacuolization  with  rounding  and  clumping  of  cells.  Virus 
assays from this experiment are presented in Text-fig. 1. No evidence of virus 
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TExT-Fro. 2.  Vacdnia virus assays in mouse/eukocytes  inoculated with a multiplicity 
of 1.0. The inoculum was removed following  4 hours' adsorption. Virus titers represent pfu/ml 
in supernatant fluid. 
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TExT-Fro. 3.  Assays of intracellular vaccirda virus in mouse leukocytes. Vaccinia virus 
titers are expressed in pfu/cell. 
multiplication was obtained, virus titers gradually decreased, and after 7 to 21 
days, depending on the input multiplicity of the inoculum,  the vaccinia virus 
could no longer be detected in the supernatant fluids. The rate of inactivation 
was  compared  with a  thermal  inactivation curve of  vaccinia  virtL~ in basal 
Eagle's medium with 15 per cent calf serum under similar incubation conditions 
and  with  that  in  replicate  cultures  of leukocytes  inactivated  by heating  at 
56  ° for 20 minutes.  Thermal inactivation curves under both conditions  were 
essentially  identical  and  are  presented  in  Text-fig.  1  as  the  control  curve. LOWELL A.  GLASGOW AND KARL H.ABEL  153 
Vaccinia virus was eliminated from the leukocyte cultures at a rate which was 
significantly more rapid than that in the two thermal inactivation controls. 
These data suggest that the viable leukocytes were contributing to the elimina- 
tion process and that minimal or no virus multiplication had taken place. 
Because of the possibility that a limited replication of virus was being masked 
by  the  remaining large  initial  inoculum, a  multiple cycle growth  curve  of 
vaccinia virus was obtained with the initial inoculum removed after virus ad- 
sorption had taken place. 
TABLE I 
Lack  of ttemagglutinin  Production  in  a  Leukocyte  Culture  after  Inoculation  with  Vaccinia 
Virus at a Multiplicity of 1.0 pfu/cell 
Time of harvest, hrs  ..........  i  0  ]  3~  7  I  11~  I  30  I  48  I  72 
Hemagglutinin  titer ..........  256  54  0  0  0  0  0 
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TExT-FIG. 4. Interferon activity, quantitated by per cent plaque reduction, in supernatant 
fluids of vaccinia infected cultures of mouse leukocytes  (A----A) primary mouse  embryo 
(0  0) and ME-29, an established mouse cell line (~---~. 
Replicate cultures of mouse leukocytes were inoculated with an input multiplicity  of 1.0. 
After a 4 hour adsorption,  the inoculum was removed, cultures  were washed three times, 
incubated at 36  °, and samples of supernate collected for virus assay. 
Results presented in Text-fig. 2 again indicate a lack of virus multiplication. 
The initial plateau in the curve of Text-fig. 2 is thought to represent elution of 
virus from cells following the washing procedure, although we have no direct 
evidence to substantiate this explanation. 
Vaccinia Eclipse in Mouse Leukocytes.--The  next experiment was designed 
to determine if vaccinia virus penetrated or was phagocytosed by leukocytes 
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Replicate cultures of leukocytes were inoculated with a multiplicity  of 1.0 pfu/cell.  Mter 
31/~ hours' adsorption the inoculum was removed, cultures were washed 3 times with Eagle's 
medium, and then treated with a  1:15 dilution of vaccinia hyperimmune  rabbit serum for 
hour. The hyperimmune serum was removed, cultures again washed 3 times and incubated 
at 37  °. At varying time intervals individual cultures were harvested, cells disrupted by sonica- 
tion and virus assayed. 
Data from this  experiment  are presented  in Text-fig.  3.  Intracellular,  non- 
neutralized virus decreased  over the 24-hour period studied and  there  was  no 
evidence of the synthesis of new infectious particles. This suggests that vaccinia 
virus entered, or at least became associated with leukocytes so that it was non- 
neutralizable by extracellular antiserum,  and subsequently was converted to a 
TABLE II 
Identity  o/  Characteristics of Leukocyte-Produced Inte, 
Stability pH 2 .................................. 
Sediment 100,000 g .............................. 
Species specificity ............................... 
Active against heterologous virus .................. 
Stability at heating 60  ° for 60 rain ................. 
Stability at heating 80  ° for 60 rain ................. 
Trypsin-sensitive ................................ 
Ceron with  Other Known  Interferons 
Leukocyte Interferon  Control Interferon 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
non-infectious form.  This apparent  intracellular  eclipse could account for the 
more rapid rate at which infectious virus was lost from the leukocyte cultures 
as compared with controls in the previous experiment. 
Lack of Hemagglutinin  Production.--Henle,  et al. (27) and Smith and Morgan 
(28)  reported  that influenza virus  in HeLa and L  cells produced a  cytotoxic 
effect with little  or no production of new infectious virus similar  to that ob- 
served in our vaccinia-leukocyte system.  In both influenza systems, however, 
virus hemagglutinin was produced in high titer. During the course of the previ- 
ous experiment,  samples  of supernatant  fluid were harvested  and assayed for 
vaccinia  hemagglutinin  activity.  Results  of  these  assays  are  presented  in 
Table  I.  Hemagglufinin  decreased  during  the  3~-hour  period  of  adsorption 
and no new hemagglufinin was produced during the course of the experiment. 
Thus vaccinia virus infection in mouse leukocytes was characterized by a cyto- 
toxic effect which was not associated with the synthesis of new infectious par- 
tic]es or the release of viral hemagglutinin. 
Interferon production  by leukocytes.-- 
Cultures of leukocytes were inoculated with vaccinia virus at a multiplicity of 0.5 to 0.75. 
Supernatant  fluids were harvested after 48 to 72 hours' incubation and assayed for interferon 
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In Text-fig. 4,  the plaque  reduction  obtained  with  serial dilutions  of this 
harvest is compared to that produced by similar dilutions of fluids harvested 
from primary mouse embryo and ME-29 (23)  cultures infected with vacclnia 
virus.  In view of a  greater cell population  in leukocyte  cultures  these  data 
should not be interpreted as demonstrating greater efficiency of interferon pro- 
duction by leukocytes on an individual cell basis. Per cent plaque reduction is 
calculated  in  relation  to  the  pfu in  control  plates  treated  with  dilutions  of 
processed spent medium from non-infected leukocyte cultures.  These results 
demonstrate that vaccinia virus-inoculated leukocyte cultures produce signifi- 
cant levels of an interferon-like substance. The properties of this substance are 
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TEXT-FIO. S.  Protective effect against VSV as the result of treatment designed to stimulate 
interferon production in peritoneal leukocytes of mice. 
shown in Table H to be identical with those previously reported for other inter- 
ferons. 
In Vivo Effect of Leukocyte-Produced  Interferon 
Protection against  Vesicular Stomatitis Virus Challenge.--in view of the above 
evidence  that  mouse  leukocytes  can  produce  interferon  after  exposure  to 
vaccinia virus in vitro, studies were initiated to determine if white cell produced 
interferon could contribute to the host's defense against virus infection in vivo. 
Mice were inoculated intraperitoneally with trypticase soy broth to stimulate a leukocytic 
ezudate. 24 hours later the test group received a 1.0 ml intraperitoneal inoculation of ultra- 
violet-inactivated vaccinia virus. After an additional 24 hours, mice were challenged intra- 
cerebrally with VSV. The control and test groups each consisted of 3 groups of 10 mice inocu- 
lated with approximately 50, 5, and 0.5 LDb0 of VSV. 
The pooled cumulative mortality of these groups is illustrated in Text-fig. 5. 
There was  a  significant degree of protection  in  the groups receiving the  in- 
activated vaccinia as manifested both by a delay in time of onset of symptoms 156  INTERFERON  PRODUCTION BY MOUSE  LEUKOCYTES 
and by a reduced final mortality. Differences between control and test groups 
were significant at the 1 per cent level using the Kolmogorov-Smirnov test. 
Ultraviolet inactivated virus was used because it is known to induce inter- 
feron production (23),  yet no virus multiplication and minimal spread of in- 
activated virus particles to the CNS would be expected. By these means we 
hoped to minimize the possibility of direct viral interference affecting the course 
of the subsequent virus challenge. Samples  of peritoneal  exudate, blood and 
brain, collected 48 hours after inoculation, were assayed and found to contain 
no infectious virus. 
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TExT-FzG.  6.  Protective effect on VSV infection in mice by transfer of leukocytes stimu- 
lated to produce interferon in vitro. 
Interferon Production by Leukocytes Exposed to Inactivated Vaccinia Virus in 
Vivo,-- 
Twenty-four to forty-eight hours after animals in the previous experiment were inoculated 
with the inactivated vaccinia virus the leukocytic peritoneal exudate was harvested from one 
group of test animals and from control mice which had received trypticase soy broth, but no 
inactivated vacclnia virus. Cells from both groups were maintained in tissue culture as previ- 
ously described. After 48 to 72 hours supernatant fluids were harvested, pH-treated, and as- 
sayed for interferon activity. 
Preparations from the cultures of leukocytes exposed to ultraviolet inacti- 
vated vaccinia virus in vivo effected a  50-79 per cent reduction in plaques in 
comparison  with  the  control  preparations.  These  results  demonstrate  that 
leukocytes exposed to virus in vivo are capable of producing interferon and are 
consistent with the hypothesis that leukocyte-produced interferon contributed 
to the observed protection against the VSV challenge. 
Protection of Mice against VSV Challenge by Transfer of Leukocytes Exposed 
to Inactivated Vaccinia Virus in Vitro.--In order to localize the protective effect 
demonstrated in the previous experiment  to  the leukocytes and  to relate it 
directly to the production of interferon by those cells, an experiment was de- LOWELL  A.  GLASGOW AND  KARL  HABEL  157 
signed  where  isologous  leukocytes,  exposed  to  inactivated  vaccinia  virus  in 
vitro, were transferred to normal mice. Recipient and control animals were then 
challenged with VSV inoculated intracerebrally. 
Leukocytic exudate stimulated in the peritoneal cavity of inbred  BALB/c mice was har- 
vested and incubated in vitro for 3 hours with ultraviolet inactivated vacdnia virus. In order 
to minimize residual virus the cells were then centrifuged at 800 ~  for 10 minutes, washed 
in Eagle's medium, recentrifuged, and finally resuspended in Eagle's medium. Control leuko- 
cyte preparations received identical handling with the exception of the exposure to inactivated 
vaccinia virus.  Groups of 15 test and  control BALB/c mice received  a  1.0 ml inoculation 
intraperitoneally containing 4 to 7 X  108 virus-exposed or control leukocytes. 24 hours later 
both groups were challenged with approximately 5 LD~o of VSV. On the 4th to 5th day after 
the initial white cell transfer a second identical cell transfer was carried out. 
TABLE  III 
Interferon Activity  of Leukocytes Exposed to  UV-lnactivated  Vaccinia Virus Prior to  Their 
Transfer to Isologous Normal Mice 
Plaques  Average plaques  Plaque 
Preparation assayed  per plate  per plate  reduction 
;upernatant from WBC's q- UV vaeeinia... 
;upernatant from WBC control 
nterferon control. 
;ontrol--no treatment 
.[  10,  9,  14 
..[  32,  29,  39 
i  7,  4,  6 
39,  35,  36 
11 
33 
6 
37 
70 
11 
84 
Cumulative mortality curves from this  experiment are presented  in Text- 
fig. 6.  Animals in the test group which had received virus-treated leukocytes 
were shown  to manifest resistance to the subsequent VSV challenge in com- 
parison to those receiving control cells. The results presented are representative 
of data obtained in 3 experiments, and the differences in mortality are signifi- 
cent at the 5 to 10 per cent level. 
Interferon  Produced by  Transferred  Leukocytes.--The  preceding  experiment 
suggested that the virus-treated leukocytes were associated with the observed 
protection  in  recipient animals.  The possible role of interferon,  however, re- 
mained to be defined. 
Samples of control and inactivated  virus-treated leukocytes used in the transfer experi- 
ment were incubated in vitro. After 48 to 72 hours supernatant  fluids were harvested, add- 
treated  as described, and assayed for interferon activity. 
Results from one such experiment presented in Table III demonstrate that 
the transferred leukocytes did produce interferon. 
DISCUSSION 
It is  apparent from numerous previous investigations  that viruses are not 
destroyed by leukocytes as rapidly or as efficiently as is the case with many 158  INTER]~ERON PRODUCTION  BY MOUSE  LEUKOCYTES 
bacterial  pathogens.  Any  contribution  of  leukocytes  to  the  host's  defense 
mechanism in viral infections, however, has remained undefined. A number of 
viruses have been shown not to multiply in white cells and many of those that 
do replicate appear  to achieve relatively low titers. We have considered the 
question of what function, if any, do leukocytes have in the host's defense 
against viruses. Recently published experimental results have strongly suggested 
that interferon may play an important role in the ability of the host to recover 
from virus infections. The association of white cells  with interferon demon- 
strated in the present studies permits one to postulate a  possible function of 
leukocytes. 
Many viruses are taken up by leukocytes in vivo, but fail to multiply or do so 
relatively inefficiently. The result of this virus-cell interaction would be the pro- 
duction of interferon. This interferon would then be available to prevent ex- 
tension of the virus infection to new susceptible cells and thus contribute to the 
elimination of the virus. The ability of leukocytes to accumulate at the local 
site of infection would enhance the effectiveness of the interferon produced by 
these cells.  Although the evidence presented here establishes the capacity of 
white cells to produce interferon, quantitative data necessary to define the rela- 
tive contribution of leukocytes to the defense of the host is still lacking. 
Gresser and Enders (29) have recently demonstrated that a small population 
of resistant, interferon-producing cells in a culture of susceptible cells may alter 
the course of a virus infection in that culture. Our results suggest that white 
cells or reticuloendothelial system macrophages may perform a similar function 
in vivo. The observed persistence of virus particles in leukocytes may actually 
contribute to the recovery process by effecting a continued stimulation of inter- 
feron production. The present study tends to support such a hypothesis. Vac- 
cinia virus has been observed to persist in white cells in vivo by Smith (6) and 
in vitro by Sabin (5)  and in the present study. No new infectious virus was 
formed, but leukocytes so infected were shown to produce significant levels of 
interferon in vitro. The data also suggest that leukocytes produced interferon 
in  vivo and  that leukocyte-produced interferon contributed to  the observed 
attenuation of the course of a VSV infection in mice. 
SUMMARy 
Vaccinia virus penetrates, or is phagocytosed by, mouse leukocytes in vitro. 
A cytotoxic effect is observed, but no new infectious virus is produced. Vac- 
cinia virus, as infectious particles, is eliminated from a culture of leukocytes at 
a more rapid rate than can be accounted for by thermal inactivation. Leuko- 
cytes infected with vaccinia virus produce a substance with the properties of 
interferon. The evidence presented suggests that leukocytes also produce inter- 
feron in ~ivo and that this interferon is related to the observed protective effect 
on the outcome of intracerebral vesicular stomatitis virus challenge in mice. It is LOWELL A.  GLASGOW AND KARL HABEL  159 
postulated that leukocytes, in this manner, may make a  positive contribution 
to the host's defense mechanism and to the process of recovery from viral in- 
fections. 
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EXPLANATION  OF PLATE 1 
FIG. 1.  Cytotoxic effect of vaccinia virus on mouse leukocytes inoculated with a 
multiplicity of 1.0 and cultured for 48  to 72 hours.  ×  430. 
FIG. 2. Absence of obvious cytotoxic effect in a leukocyte culture inoculated with 
0.1  pfu/cell of vaccinia virus and  cultured  for 48  to  72  hours.  ×  430 THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 117  PLATE  1 
(Glasgow and Habeh  Interferon production by mouse leukocytes) 